Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies - Episode 8

Defining active SPMS

December 11, 2020

EP. 1: Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies EP8

EP. 2: Challenges Regarding Coverage for New SPMS Therapies

EP. 3: Evolving Treatment Strategies and Coverage Implications

EP. 4: The Clinical and Economic Burden of SPMS

EP. 5: Determining SPMS as Biological Instead of Classification

EP. 6: Tackling Secondary Progressive Multiple Sclerosis Early on Benefits Patients in a Number of Ways

EP. 7: Biomarkers Used to Detect Secondary Progressive MS Needs Improvement for the Care of Patients

EP. 8: Defining active SPMS

EP. 9: How Patients Present SPMS, How to Act on it

EP. 10: A Labeling Indication of SPMS Can Treat More Patients

EP. 11: The Struggle of Making an Effective SPMS Treatment Early on

EP. 12: Unmet Needs for All and Most Vulnerable Secondary Progressive MS Patients